Timing & pharmacokinetics
How long does Ginkgo Biloba take to work?
Onset timing for Ginkgo Biloba varies in the clinical literature. Onset timing is not well-quantified in our dataset, refer to clinical citations on the main entry.
Onset
–
Half-life
5h
Duration
–
Timing
AM/midday
Key facts
- typical dose
- 120–240 mg
- dose frequency
- 1-2 doses
- timing
- AM/midday
- with food
- with meal
- half-life
- 5 hours
- safety score
- 4/5
- evidence grade
- B
- class
- herb
- PubMed citations
- 4200
- legal status (US)
- Over-the-counter
- legal status (UK)
- Over-the-counter
- legal status (EU)
- Over-the-counter
- legal status (AU)
- Over-the-counter
- primary mechanism
- Increases cerebral and peripheral blood flow via vasodilation and improved erythrocyte deformability.
Onset window
Ginkgo Biloba onset times in the published literature vary widely. Refer to the citations on the main Ginkgo Biloba entry for compound-specific pharmacokinetic data.
Food effect: Taking with food slows absorption but improves tolerance. Onset shifts 30–60 minutes later than empty-stomach dosing.
Half-life and dosing frequency
Moderate 5-hour half-life, a single morning dose usually covers the workday.
Acute vs. chronic effect
Some nootropics work the first time you take them (Ginkgo Biloba may or may not). Others, adaptogens, racetams, and most botanicals targeting BDNF or NGF pathways, require 2–4 weeks of daily dosing before the full effect emerges.
If you don’t feel anything after a single dose and the compound is in the chronic-effect category, that is normal, extend the trial to 2–4 weeks before evaluating. If it is in the acute category and you feel nothing, consider dose, vendor sourcing, or whether the compound matches your goal.
Protocol note from the Ginkgo Biloba entry
Standardize to EGb 761 (24% flavonoids, 6% terpenoids).
Mechanism, safety, and citations for Ginkgo Biloba are on the main reference page, see Ginkgo Biloba. For full dose protocol see Ginkgo Biloba dosage. To check for stack-level pharmacokinetic conflicts, use the interaction checker.
Onset and pharmacokinetic data reflect the published literature for healthy adults at typical doses. Individual variation in absorption, metabolism (CYP genotype), and gut transit can shift onset by ±50%. This page is informational and not medical advice. See our full disclaimer.